Dr. Damon Reed Gives Sarcoma Update at ASCO 2022

Dr. Damon Reed Gives Sarcoma Update at ASCO 2022

ASCO 2021 - Damon Reed, MD - Abstract 11514Подробнее

ASCO 2021 - Damon Reed, MD - Abstract 11514

SARCOMA CONNECT Update from ASCO 2022Подробнее

SARCOMA CONNECT Update from ASCO 2022

OsteoBites S1 Ep22: Damon Reed, MD: "Moffitt Osteosarcoma Research Approach ”Подробнее

OsteoBites S1 Ep22: Damon Reed, MD: 'Moffitt Osteosarcoma Research Approach ”

Unesbulin plus dacarbazine demonstrates promising efficacy in patients with advanced leiomyosarcomaПодробнее

Unesbulin plus dacarbazine demonstrates promising efficacy in patients with advanced leiomyosarcoma

Meet Dr. Damon Reed, a Leader in Pediatric Cancer Research at Moffitt Cancer CenterПодробнее

Meet Dr. Damon Reed, a Leader in Pediatric Cancer Research at Moffitt Cancer Center

SARC Talk Episode 12 - Dr. Damon Reed - Tumor BoardПодробнее

SARC Talk Episode 12 - Dr. Damon Reed - Tumor Board

ASCO 2021 - Damon Reed, MD - Abstract TPS11577Подробнее

ASCO 2021 - Damon Reed, MD - Abstract TPS11577

Dr. Damon Reed at ASCO 2023: Abstract No. 11527Подробнее

Dr. Damon Reed at ASCO 2023: Abstract No. 11527

Key data in sarcoma presented at ASCO 2022Подробнее

Key data in sarcoma presented at ASCO 2022

Sarcoma Treatment with Targeted Therapies: ImmunotherapyПодробнее

Sarcoma Treatment with Targeted Therapies: Immunotherapy

Dr. Matthew Hemming on treating sarcomas | Dana-Farber Cancer InstituteПодробнее

Dr. Matthew Hemming on treating sarcomas | Dana-Farber Cancer Institute

The current landscape for sarcoma immunotherapy treatmentsПодробнее

The current landscape for sarcoma immunotherapy treatments

Highlights from ESMO Sarcoma & GIST 2022Подробнее

Highlights from ESMO Sarcoma & GIST 2022

Updates in Sarcoma: 2023 West OncologyПодробнее

Updates in Sarcoma: 2023 West Oncology

The WarriorsПодробнее

The Warriors

Sarcoma Cancer Research and Treatment Options: RecapПодробнее

Sarcoma Cancer Research and Treatment Options: Recap

2021 West Oncology APP | Update on SarcomaПодробнее

2021 West Oncology APP | Update on Sarcoma

Bladder cancer at ASCO 2022: RC48 vedotin, chemoimmunotherapyПодробнее

Bladder cancer at ASCO 2022: RC48 vedotin, chemoimmunotherapy

SARCOMA TREATMENT OVERVIEWПодробнее

SARCOMA TREATMENT OVERVIEW